Amrutanjan Health Care Limited (BOM: 590006)
India
· Delayed Price · Currency is INR 701.00
+15.70 (2.29%)
At close: Nov 14, 2024
Amrutanjan Health Care Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 475.2 | 449.73 | 398.35 | 671.89 | 611.9 | 250.83 | Upgrade
|
| Depreciation & Amortization | 55.01 | 52.08 | 44.18 | 36.56 | 35.04 | 41.95 | Upgrade
|
| Other Amortization | 8.49 | 8.49 | 7.94 | 1.39 | 1.66 | 1.64 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.05 | -1.57 | -0.27 | - | -0.89 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.11 | 1.11 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.16 | 1.26 | 2.05 | 1.41 | 3.67 | -10.66 | Upgrade
|
| Stock-Based Compensation | 5.02 | 2.15 | 4.38 | -0.11 | 6.18 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 23.59 | 20.99 | 4.64 | 3.99 | 15.98 | 24.1 | Upgrade
|
| Other Operating Activities | -140.51 | -153.25 | -163.04 | -153.89 | -70.96 | -83.18 | Upgrade
|
| Change in Accounts Receivable | -35.04 | -169.68 | 47.72 | -209.92 | 72.55 | 40.95 | Upgrade
|
| Change in Inventory | -17.42 | -0.8 | -28.24 | -85.42 | 62.57 | -91.39 | Upgrade
|
| Change in Accounts Payable | -55.64 | 95.41 | -106.67 | 236.79 | 94.99 | 16.19 | Upgrade
|
| Change in Other Net Operating Assets | -70.46 | -26.81 | -9.22 | 19.27 | 76.01 | -8.68 | Upgrade
|
| Operating Cash Flow | 249.46 | 279.11 | 201.81 | 521.96 | 908.69 | 181.76 | Upgrade
|
| Operating Cash Flow Growth | -31.51% | 38.30% | -61.34% | -42.56% | 399.94% | -14.14% | Upgrade
|
| Capital Expenditures | -68.08 | -67.18 | -89.27 | -234.63 | -19.61 | -25.44 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.06 | 2.59 | 0.44 | - | 0.89 | - | Upgrade
|
| Investment in Securities | -222.09 | 115.04 | -48.25 | -253.82 | -915.27 | -174.53 | Upgrade
|
| Other Investing Activities | 142.4 | 141.2 | 112.33 | 126.34 | 56.38 | 61.47 | Upgrade
|
| Investing Cash Flow | -146.71 | 191.65 | -24.75 | -362.12 | -877.61 | -138.5 | Upgrade
|
| Long-Term Debt Repaid | - | -5.57 | -5.8 | -6.92 | -6.42 | -5.64 | Upgrade
|
| Total Debt Repaid | -4.86 | -5.57 | -5.8 | -6.92 | -6.42 | -5.64 | Upgrade
|
| Net Debt Issued (Repaid) | -4.86 | -5.57 | -5.8 | -6.92 | -6.42 | -5.64 | Upgrade
|
| Issuance of Common Stock | 14.11 | 11.79 | - | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | -355.02 | - | -35.34 | -9.64 | - | Upgrade
|
| Common Dividends Paid | -133.86 | -133.86 | -144.09 | -124.77 | -57.83 | -62.85 | Upgrade
|
| Other Financing Activities | - | - | - | - | -0.33 | -19.19 | Upgrade
|
| Financing Cash Flow | -124.61 | -482.66 | -149.89 | -167.02 | -74.23 | -116.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | -0 | -0.01 | -0.01 | Upgrade
|
| Net Cash Flow | -21.86 | -11.91 | 27.17 | -7.19 | -43.16 | -73.65 | Upgrade
|
| Free Cash Flow | 181.38 | 211.93 | 112.54 | 287.32 | 889.09 | 156.32 | Upgrade
|
| Free Cash Flow Growth | -39.63% | 88.31% | -60.83% | -67.68% | 468.77% | -18.28% | Upgrade
|
| Free Cash Flow Margin | 4.13% | 5.03% | 2.96% | 7.08% | 26.70% | 5.97% | Upgrade
|
| Free Cash Flow Per Share | 6.27 | 7.30 | 3.85 | 9.83 | 30.41 | 5.35 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.33 | 0.26 | Upgrade
|
| Cash Income Tax Paid | 164.97 | 164.97 | 160.63 | 241.92 | 186.97 | 130.44 | Upgrade
|
| Levered Free Cash Flow | -1,404 | 250.33 | 45.23 | 293.5 | 816.5 | 159.61 | Upgrade
|
| Unlevered Free Cash Flow | -1,403 | 251.31 | 45.71 | 296.53 | 819.63 | 160.99 | Upgrade
|
| Change in Net Working Capital | 1,719 | 39.52 | 183.11 | 5.68 | -347.65 | 24.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.